Related Experiment Video
Updated: May 23, 2026
18:57
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
The development and implementation of pharmaceutical care across borders
H van den Brink1, I Nanthini Haridass, V Siranyan
1Faculté de pharmacie, université Paris-Sud 11, 5, rue Jean-Baptiste-Clément, 92290 Châtenay-Malabry, France. helene.van-den-brink@u-psud.fr
Annales Pharmaceutiques Francaises
|April 17, 2012
Summary
Community pharmacists are vital for healthcare. Recent legislative changes in Europe, including France, are redefining their roles to prioritize patient care, mirroring reforms seen in Canada.
Area of Science:
- Pharmacy Practice
- Healthcare Policy
- Public Health
Background:
- Community pharmacists are integral to high-standard healthcare delivery.
- Traditional roles may not fully encompass evolving patient care needs.
- European and national indicators highlight the need for task redefinition.
Purpose of the Study:
- To analyze the evolving role of community pharmacists in Europe.
- To examine legislative changes impacting community pharmacy practice.
- To compare recent French reforms with international models, such as Canada's.
Main Methods:
- Review of legislative changes across EU member states.
- Analysis of national reports and reform proposals concerning community pharmacy.
- Comparative study of French healthcare reforms and Canadian pharmacy practices.
Main Results:
- Several European countries have updated legislation to broaden pharmacist responsibilities.
- A shift towards patient-centered care is evident in European pharmacy practice.
- French reforms share similarities with Canadian approaches to community pharmacy services.
Conclusions:
- Community pharmacy is undergoing a significant role transformation across Europe.
- Legislative reforms are crucial for enhancing pharmacists' contribution to patient care.
- International comparisons offer valuable insights for optimizing pharmacy services.
Related Concept Videos
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:24Cellular Membranes and Drug Transport
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...